Late Graft Loss: Proceedings of the 28th Conference on Transplantation and Clinical Immunology, 3-5 June, 1996 (Hardcover, 1997)

1. Chronic graft loss in kidney and heart transplant recipients.- 2. Histopathology of chronic rejection.- 3. Evaluation of biopsy changes in the early diagnosis of chronic transplant nephropathy.- 4. Is there any relationship between the early glomerular filtration rate and late graft dysfunction in renal transplantation?.- 5. Transplantation atherosclerosis: Definition and pathogenesis.- 6. Immunological mechanism of chronic rejection.- 7. The role of adhesion molecules in chronic rejection.- 8. A role for TH2 cells in chronic allograft rejection?.- 9. Treatment of refractory acute allograft rejection with aerosolized cyclosporin in lung transplant recipients.- 10. Ischemia-reperfusion injury as a risk factor for late kidney graft failure.- 11. The impact of acute rejection in the longterm outcome after renal transplantation.- 12. Nephron endowment and the pathogenesis of chronic renal failure.- 13. Are child donors better than adult donors for pediatric kidney recipients?.- 14. Late graft loss in combined kidney-pancreas transplantation.- 15. Longterm allograft outcome in patients treated with prophylactic antilymphocyte globulin or OKT3 as induction therapy in cadaveric kidney transplantation.- 16. Cyclosporin - longterm treatment.- 17. Effect of new immunosuppressive drugs on chronic rejection.- 18. Experimental transplantation in rats for the study of the pathogenesis and treatment of chronic rejection.- 19. The effects of HMG-CoA reductase inhibitors after kidney and heart transplantation: Lipid lowering and immunosuppression.- 20. Lipid metabolism alteration and treatment in heart transplant recipients.- 21. Prevention and treatment of cytomegalovirus (CMV) disease.- 22. Longterm renal function protection in renal transplantation by nonimmunological treatments.- Clinical impact and predictive role of OGTT as a marker of longterm loss of function in patients submitted to pancreas transplantation.- Influence of recipient - donor body weight ratio in pediatric renal transplantation.- Survival, rejection, tumors and infections 5 years after liver transplantation.- Comparison of dipyridamole thallium scintigraphy and dobutamine stress echocardiography to detect graft coronary artery disease in heart transplant patients.- Immunohistochemical profile in asymptomatic acute rejection of renal allografts: Predictive marker of graft loss.- High sodium UW cold-storage solution improves kidney graft function in rats.- Influence of natural selection haplotypes on longterm survival in renal transplantation from haploidentical living related donors.- Posttransplant immunological monitoring by ELISA: HLA-specific IgG antibodies are associated with early and late graft loss events.- Longterm benefit of additional azathioprine in cyclosporin/prednisolone-treated patients with chronic renal allograft dysfunction.- Effect of steroid withdrawal on late immunologic complications after liver transplantation.- Effect of angiotensin converting enzyme inhibitors (ACEI) on the progressive graft failure and proteinuria in kidney transplant patients with chronic rejection.- ATG prophylaxis preoperatively reduced acute rejections - a predicting factor on long graft survival.- Kidney transplantation in children at our center.- Kidney transplantation between spouses.- Oxidative stress and lipid abnormalities during chronic rejection of kidney transplantation.- Proton NMR spectroscopy as a novel approach to the assessment of function in the pig isolated kidney exposed to cold ischemia.- Renal handling of citrate excretion during reperfusion after cold storage in the isolated perfused pig kidney.- The improvement of early rat kidney graft function after perfusion with HTK solution supplemented with pentoxifylline.- Nifedipine improves kidney function after 24 h cold storage in a high-sodium UW solution.- Preventing cadaveric grafted kidney from acute rejection with anti-thymocyte globulin.- Study of the pharmacokinetics of the Neoral® formulation of